![Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01492/asset/images/large/jm-2018-01492k_0019.jpeg)
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
![PDF) The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein PDF) The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein](https://i1.rgstatic.net/publication/360595306_The_absentlow_expression_of_CD34_in_NPM1-mutated_AML_is_not_related_to_cytoplasmic_dislocation_of_NPM1_mutant_protein/links/627fba1c3a23744a727feff2/largepreview.png)
PDF) The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein
![CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression - ScienceDirect CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120621176-gr1.jpg)
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression - ScienceDirect
![CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression - ScienceDirect CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120621176-fx1ab.jpg)